New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
January 26, 2022, the FDA approved Lupin Pharmaceuticals’ Solosec (secnidazole).
Download PDF
Return to publications
